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A 3-day scientiﬁc workshop titled “Regulatory
Acceptance of (Q)SARs for Human Health
and Environmental Endpoints,” hosted by the
European Centre for Ecotoxicology and
Toxicology of Chemicals and organized by
the International Council of Chemical
Associations (ICCA) and the European
Chemical Industry Council (CEFIC; as part of
their long-range research initiative) was held
4–6 March 2002 in Setubal, near Lisbon,
Portugal, Participants of the Setubal workshop
had a diverse background both in human and
environmental safety and in associations with
academic institutions, government bodies, or
industry from Europe, North America, and
Japan. Participants agreed that the workshop
initiated great potential for the further devel-
opment of predictive models and their applica-
tion for chemicals management, including
priority setting, risk assessment, and classiﬁca-
tion and labeling.
One of the key messages during the work-
shop was that both industry and regulatory
authorities share the same goal, that is, to use
quantitative structure–activity relationships
[(Q)SARs] in a much broader scope than cur-
rently practiced for safety evaluation and
chemicals management. Consequently, there
was a clear agreement on the need to continue
dialogue and cooperation.
(Q)SARs are simpliﬁed mathematical rep-
resentations of complex chemical–biological
interactions. They can be divided into two
major types, QSARs and SARs. QSARs are
all quantitative models yielding a continuous
or categorical result. The most common tech-
niques for developing QSARs are regression
analysis, neural nets, and classiﬁcation meth-
ods. Examples of regression models include
ordinary least squares and partial least
squares, whereas for neural nets back-propa-
gation methods would be commonly used.
Examples of classification methods are dis-
criminant analysis, decision trees, and dis-
tance-based similarity analysis. SARs are
qualitative relationships in the form of struc-
tural alerts that incorporate molecular sub-
structures or fragments related to the presence
or absence of activity.
(Q)SAR predictions have the potential to
save time and money and minimize the use of
animal testing. However, to fulﬁll this poten-
tial, the predictions, especially those considered
for regulatory decision making, need to be sci-
entifically valid, appropriate for the purpose
intended, reliable, and accepted by decision
makers. Approaches to determine the accept-
ability of (Q)SARs have been developed in the
past [e.g., guidance from the Organisation for
Economic Development (OECD)], but
because of their breadth and generality, they
have not been widely applied or respected by
either (Q)SAR users or developers. As a conse-
quence, decision making with the help of exist-
ing models must be done with care and
considerable knowledge. The workshop in
Setubal aimed at reopening the debate to
develop more speciﬁc guidance and acceptabil-
ity criteria and a system that would support the
use of (Q)SARs such that the guidance and
acceptability criteria were actually applied
when a (Q)SAR was used for chemicals man-
agement purposes.
Acceptability Criteria for (Q)SARs
(Q)SAR predictions are derived from sim-
plified mathematical representations of
complex chemical–biological interactions and,
consequently, are potentially more uncertain
than the underlying test data. This imposes
limitations on the acceptable scope of a
(Q)SAR use in chemicals management and
decision making. The general acceptability cri-
teria developed for alternative methods to ani-
mal testing by the European Center for the
Validation of Alternative Methods were dis-
cussed in the context of (Q)SARs and were
fully accepted. These criteria indicate that an
alternative model should a) be associated with
a defined end point that it serves to predict;
b)1359take the form of an unambiguous and
easily applicable algorithm for predicting a
pharmacotoxicologic end point; c) ideally have
a clear mechanistic basis; d) be accompanied
by a deﬁnition of the domain of its applicabil-
ity, for example, the physicochemical classes
of chemicals for which it is applicable; e) be
associated with a measure of its goodness of ﬁt
and internal goodness of prediction estimated
with cross-validation or similar method to a
training set of data; and f ) be assessed in
terms of its predictive power by using data
that were not used in the development of the
model (external validation).
The workshop participants agreed that
(Q)SARs are one of the alternative methods to
animal testing, and therefore, these generic cri-
teria can and should be further reﬁned speciﬁ-
cally for (Q)SARs. The acceptability criteria
were divided into two components, statistical
and nonstatistical. The discussions on statistical
criteria centered on proposals circulated before
the meeting, which focused on the regression
and two-way classiﬁcation models. As a result
of the quantitative nature of these criteria, it
was possible to make them very speciﬁc.
Specific criteria for continuous QSAR
models. One of the clear outcomes was that for
regulatory purposes a QSAR’s predictive
power and the prediction uncertainty must be
reported along with the goodness of fit.
Typical values were recommended, and it was
agreed these should be used in the subsequent
testing of the criteria.
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Again, values describing goodness of fit,
including speciﬁcity, sensitivity, and negative
and positive predictive power, were proposed
and accepted. Another factor that needs to be
evaluated is the minimization of false posi-
tive/negatives by sequential use of models.
Speciﬁc criteria for SARs. The issues arising
from the need to assess such models were felt
to be model speciﬁc, but clearly included simi-
larity analysis. It was recognized that further
research was needed to address SARs and the
application of expert knowledge models.
Nonstatistical criteria for (Q)SARs. The
nonstatistical criteria discussed were associated
with the endpoint, chemical descriptors, mech-
anism, domain, and transparency. In particu-
lar, it was agreed that predictive models should
be transparent. Transparency in this context
means that there should be access to the train-
ing and validation data sets as well as to the
methods used for the development and valida-
tion of the model. Thus, an informed user
with the correct tools would be able to
re-create the model using the same data and
techniques as the original developer.
Another outcome of the discussion about
nonstatistical criteria was realization of the dif-
ference between human health and environ-
mental predictive models because of differences
in the nature of the endpoints studied. In gen-
eral, QSARs for environmental endpoints are
founded on relatively large quantitative data-
bases with sufﬁcient mechanistic understand-
ing to enable the model to have useful
predictive capability. Furthermore, it is rela-
tively easy to support the prediction with sub-
sequent testing. In contrast, the ability to
predict local effects in humans is currently lim-
ited by a lack of good quality data and, conse-
quently, has limited regulatory use. For
systemic human health endpoints, the models
are poor because the traditional endpoints
(e.g., LD50, no-observable-adverse-effect level,
lowest-observable-adverse-effect level),
although suitable for current methods of
chemicals management, are not suitable for
(quantitative) modeling. These complex
human health endpoints are expressed through
many different mechanisms, are often receptor
mediated, and are multistage processes com-
prising absorption, distribution, metabolism,
and excretion (ADME), frequently with site-
speciﬁc interactions. Furthermore, it was con-
cluded that often the endpoints were not
defined by a clear dose response and that
steady-state concentrations in animals were
often not achieved. In the light of these discus-
sions, the workshop participants felt that fur-
ther work was needed to increase the
availability of good quality data where possible.
It was also recognized that before attempting
improvements to the predictive models for
complex in vivo human health endpoints, the
existing methods needed to be evaluated for
their potential to generate additional data more
useful for modeling purposes. It should be
noted that, because of lack of appropriate
experts, the workshop participants did not
extensively discuss reproductive toxicity and
repeated dose effects.
Future QSAR Applications
By developing the acceptability criteria, the
workshop participants agreed that considerable
progress had been made in reﬁning when and
which (Q)SARs can support chemicals man-
agement decisions. This was recognized as a
convergence of industry and regulatory agency
positions regarding the scope of QSAR use and
an acceptance that both positive and negative
assignment of a chemical can be achieved with
(Q)SAR models. Participants agreed on the
following points:
• Acceptable levels of uncertainty in a predic-
tion will depend upon the chemical manage-
ment decision being made; that is, the model
should be ﬁt for purpose.
• The smaller the change in a prediction that
would affect a decision, the more certain that
prediction should be. This means that there
will need to be a balance between the accu-
racy of a (Q)SAR prediction and the (Q)SAR
applicability domain, depending upon the
decision to be made.
• Uncertainty in a prediction should always be
considered in the light of the underlying vari-
ability of the experimental data. If the predic-
tion uncertainty matches the inherent
variability associated with the endpoint, then
animal testing should be avoided.
It was thus concluded that if the uncer-
tainty of the prediction were such that a
“wrong” decision might be made, targeted test-
ing could be conducted to confirm the data
point. In other circumstances, the (Q)SAR
prediction would be judged acceptable and no
testing would be warranted.
The workshop participants assumed a sce-
nario with a (Q)SAR that met all the validation
and acceptability requirements previously
agreed. It was agreed that such a (Q)SAR could
potentially be used for prioritization, risk
assessment, and/or classiﬁcation and labeling.
It was felt that (Q)SARs appear to be most use-
ful for risk-based priority setting, for risk assess-
ment at the lower tiers of the assessment, and
for rational prioritization for testing and test
design. In this way, it is possible to evaluate
whether the substance would trigger specific
concerns on the basis of structural alerts, ana-
log information, or (Q)SAR. The tiered
approach in risk assessment allows for the col-
lection of more accurate effects data and, if
warranted, guides further and higher tier ani-
mal testing. Such a tiered approach will also
help in decisions on test species selection. For
example, a conﬁrmatory test with one of the
most sensitive species could be made instead of
simultaneously generating data on all species of
a regulatory scheme. If a prediction and an
experimental value agree, then further testing
could be derogated and QSAR results for the
other species could be used.
The workshop participants recognized
that, until recently, there had been limited
regulatory uses of (Q)SARs. The major use had
been in the support of chemical assessment and
notification in the United States. In the last
few years, this had begun to change, as both
within the European Union (Denmark, the
Netherlands) and in other countries (e.g.,
Canada and Japan), programs are being devel-
oped that will considerably increase the use
of (Q)SARs.
Management of Accepted (Q)SAR
Models
It was acknowledged that there is no rigorous
framework for the use of (Q)SAR. The work-
shop participants agreed that such a framework
is needed because this will support the users,
both regulatory and industry, in their decision
making. The system discussed had the follow-
ing key elements: a) transparent databases with
flexible search engines, b) validated (Q)SAR
models that meet agreed acceptability criteria,
c) a biotransformation and metabolic simula-
tion model
It was also recognized that such a system,
regardless of its complexity, should be user
friendly, incorporate tools to aid the selection
of appropriate (Q)SARs, and be generally avail-
able via the Internet. The workshop agreed
that such a decision support framework should
attempt to help non-QSAR experts choose the
most appropriate models, thus aiding them in
the decision-making process.
The decision support system should be
dynamic, that is, should allow for the continu-
ous refinement of existing (Q)SARs. It is
expected that, when the acceptability criteria
are properly applied to a (Q)SAR, there will
not be a major impact on chemical-specific
predictions. With consequent model improve-
ments, the predictions for “old” structures
would not be signiﬁcantly altered. Rather, the
models would improve through expansion of
the applicability domain and thus predictions
for structures not previously covered by the
(Q)SAR. It was recognized, however, that this
was an area where further work is needed to
help build confidence by all users in the
approaches being advocated.
The decision support system should be
supported and maintained by an independent
organization that can hold data (experimental
or models) and/or validate data and models.
This organization might also be a potential
holder of proprietary data or provide a mecha-
nism for better sharing of data between model
developers.
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Actions and Recommendations
Three review papers were circulated among
participants before the workshop and provided
a common background and helped in the dis-
cussions (Cronin et al. 2003a, 2003b; Eriksson
et al. 2003).
These papers have been invited for publica-
tion in Environmental Health Perspectives
together with this summary of the workshop.
The workshop urged industry to take the
lead to further develop the acceptability crite-
ria and test existing (Q)SARs against the pro-
posed criteria for use with the various
applications, that is, priority setting, risk
assessment, and classiﬁcation. This exercise is
felt to be necessary to quickly build general
confidence in QSAR use for these purposes
and especially to address the acceptability of
both negative and positive classifications by
all interested parties. This work would then
be used to further the development of an
appropriate decision support system.
This would have the additional beneﬁt of
enhancing research within industry to focus on
development and selection of alternative chem-
icals, which was a key component of the pro-
posed U.S. Sustainable Futures program
(http:/www.epa.gov/chemrtk.volchall.htm),
and the European Union White Paper on New
Chemical Policy (http://europa.eu.int/comm/
environment/chemicals/whitepaper.htm).
Although it was recognized that the U.S.
Environmental Protection Agency’s High
Production Volume Chemicals Challenge pro-
gram (http://www.epa.gov/chemrtk/volchall.
htm) was unlikely to generate large volumes of
new data, the data it will generate should be
used to validate existing (Q)SARs, to add to or
to develop new (Q)SARs, and to further test
the proposed criteria.
The recommendations from the workshop
regarding the need for acceptability criteria,
validation of (Q)SAR models for the purpose
of regulatory applications were submitted to
OECD. In response, in November 2002
OECD initiated a (Q)SAR program by form-
ing an ad-hoc expert group that developed a 2-
year work plan. The work plan was approved
in June 2003 by the OECD joint meeting and
contains the following items:
• Apply the principles agreed upon at the ICCA
Workshop on Regulatory Acceptance of
(Q)SARs and the general OECD validation
principles for new and updated test methods
to selected (Q)SARs for regulatory use.
• Develop guidance documents for develop-
ment, validation, and regulatory acceptance
of (Q)SARs.
• Identify practical approaches to enable
(Q)SARs to be readily available and accessi-
ble, including the development of a database
of accepted (Q)SARs. 
The work will be undertaken within the
Test Guidelines Programme. Involvement of
OECD member countries and other stakehold-
ers in revising and expanding the current
OECD guidance on (Q)SARs along the lines
described by the workshop will be a very
important driver in expanding the role for, and
reliance on, (Q)SARs in regulatory decision
making.
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